Archives of Women's Mental Health

, Volume 9, Issue 3, pp 151–157 | Cite as

Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies

  • A. H. Clayton
  • R. S. Stewart
  • R. Fayyad
  • C. M. Clary
Original contribution


Objective. Gender differences in clinical presentation and response to sertraline treatment were examined for patients diagnosed with DSM-III-R panic disorder with or without agoraphobia.

Method. Data was pooled from 4 double-blind, placebo-controlled outpatient studies (males, N = 335; females, N = 338). Two were 12-week fixed-dose studies (sertraline 50 mg vs. 100 mg vs. 200 mg) and 2 were 10-week flexible-dose studies (sertraline 50–200 mg). Primary outcome measures consisted of the Clinical Global Impression-Improvement scale (CGI-I) and change in panic attack frequency.

Results. The clinical presentation of panic disorder was similar except that men reported an earlier age of onset, shorter duration of illness, and significantly more frequent history of alcohol and/or substance dependence/abuse. Sertraline was significantly more effective than placebo in both women and men on the 2 primary outcome measures. When between-sex efficacy was compared, women achieved significantly greater improvement than men on panic frequency and CGI-I, but had equivalent improvement on all other measures. There was no significant between-sex difference in study completion rates, or in adverse event profiles.

Conclusions. There was a modest but consistent trend for women to show superior efficacy at the end of acute sertraline treatment. This gender effect only occasionally achieved significance, and must be confirmed by future treatment research.

Keywords: Sertraline; panic disorder; sex; inhibitors; serotonin reuptake. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amsterdam, J, Garcia-Espana, F, Fawcett, J, Quitkin, F, Reimherr, F, Rosenbaum, J, Beasley, C 1999Fluoxetine efficacy in menopausal women with and without estrogen replacementJ Affect Disord551117CrossRefPubMedGoogle Scholar
  2. Andrade, L, Eaton, WW, Chilcoat, HD 1996Lifetime co-morbidity of panic attacks and major depression in a population-based study: age of onsetPsychol Med26991996PubMedCrossRefGoogle Scholar
  3. Ballenger, JC, Wheadon, DE, Steiner, M, Bushnell, W, Gergel, I 1998Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorderAm J Psychiatry1553642PubMedGoogle Scholar
  4. Barzega, G, Maina, G, Venturello, S, Bogetto, F 2001Gender-related differences in the onset of panic disorderActa Psychiatr Scand103189195CrossRefPubMedGoogle Scholar
  5. Battaglia, M, Bernardeschi, L, Politi, E, Bertella, S, Bellodi, L 1995Comorbidity of panic and somatization disorder: a genetic-epidemiological approachCompr Psychiatry36411420CrossRefPubMedGoogle Scholar
  6. Bibb, JL, Chambless, DL 1986Alcohol use and abuse among diagnosed agoraphobicsBehav Res Ther244958CrossRefPubMedGoogle Scholar
  7. Cox, BJ, Swinson, RP, Shulman, ID, Kuch, K, Reichman, JT 1993Gender effects and alcohol use in panic disorder with agoraphobiaBehav Res Ther31413416CrossRefPubMedGoogle Scholar
  8. Dick, CL, Bland, RC, Newman, SC 1994Epidemiology of psychiatric disorders in Edmonton. Panic disorderActa Psychiatr Scand [Suppl]3764553Google Scholar
  9. Endicott, J, Nee, J, Harrison, W, Blumenthal, R 1993Quality of life, enjoyment and satisfaction questionnaire: a new measurePsychopharmacol Bull29321326PubMedGoogle Scholar
  10. Guy W (1976) ECDEU Assessment manual for psychopharmacology, revised. Rockville MD: DHEW Publication No. (ABM), pp 76–338.Google Scholar
  11. Hafner, RJ 1983Behaviour therapy for agoraphobic menBehav Res Ther215156CrossRefPubMedGoogle Scholar
  12. Hamilton, M 1959The assessment of anxiety status by ratingBr J Med Psychol325055PubMedGoogle Scholar
  13. Hollifield, M, Katon, W, Skipper, B, Chapman, T, Ballenger, JC, Mannuzza, S, Fyer, AJ 1997Panic disorder and quality of life: variables predictive of functional impairmentAm J Psychiatry154766772PubMedGoogle Scholar
  14. Johnson, MR, Lydiard, RB 1998Comorbidity of major depression and panic disorderJ Clin Psychol54201210CrossRefPubMedGoogle Scholar
  15. Kessler, RC, Davis, CG, Kendler, KS 1997Childhood adversity and adult psychiatric disorder in the US National Comorbidity SurveyPsychol Med2711011119CrossRefPubMedGoogle Scholar
  16. Kessler, RC, McGonagle, KA, Zhao, S, Nelson, CB, Hughes, M, Eshleman, S, Wittchen, H, Kendler, K 1994Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity SurveyArch Gen Psychiatry51819PubMedGoogle Scholar
  17. Lecrubier, Y, Bakker, A, Dunbar, G, Judge, R 1997A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study InvestigatorsActa Psychiatr Scand95145152PubMedGoogle Scholar
  18. Lewinsohn, PM, Gotlib, IH, Lewinsohn, M, Seeley, JR, Allen, NB 1998Gender differences in anxiety disorders and anxiety symptoms in adolescentsJ Abnorm Psychol107109117CrossRefPubMedGoogle Scholar
  19. Londborg, PD, Wolkow, R, Smith, WT, DuBoff, E, England, D, Ferguson, J, Rosenthal, M, Weise, C 1998Sertraline in the treatment of panic disorder: A multisite, double-blind, placebo-controlled fixed dose investigationBr J Psychiatry1735460PubMedCrossRefGoogle Scholar
  20. Maier, W, Buller, R 1988One year follow-up of panic disorder: outcome and prognostic factorsEur Arch Psychiatry Neurol Sci238105109PubMedGoogle Scholar
  21. Marshall, JR 1996Comorbidity and its effects on panic disorderBull Menninger Clin60A39A53PubMedGoogle Scholar
  22. McNair, DM, Lorr, M, Droppleman, LF 1971Manual for the Profile of Mood StatesEducational & Industrial Testing ServiceSan DiegoGoogle Scholar
  23. Noyes, R, Clancey, J, Hoenk, PR, Slymen, DJ 1980The prognosis of anxiety neurosisArch Gen Psychiatry37173178PubMedGoogle Scholar
  24. Noyes, RJ, Reich, J, Christiansen, J, Suelzer, M, Pfohl, B, Coryell, WA 1990Outcome of panic disorder: relationship to diagnostic subtypes and comorbidityArch Gen Psychiatry47809818PubMedGoogle Scholar
  25. Pohl, RB, Wolkow, RM, Clary, CM 1998Sertraline in the treatment of panic disorder: a double-blind multicenter trialAm J Psychiatry15511891195PubMedGoogle Scholar
  26. Pollack, MH, Otto, MW, Worthington, J, Manfro, G, Wolkow, R 1998Sertraline in the treatment of panic disorder. A flexible-dose multicenter trialArch Gen Psychiatry5510101016CrossRefPubMedGoogle Scholar
  27. Pollack, MH, Rapaport, MH, Clary, CM, Mardekian, J, Wolkow, R 2000Sertraline treatment of panic disorder: reponse in patients at risk for poor outcomeJ Clin Psychiatry61922927PubMedGoogle Scholar
  28. Schneider, LS, Small, GW, Hamilton, SH, Bystritsky, A, Nemeroff, CB, Meyers, BS 1997Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trialAm J Geriatric Psychiatry597106Google Scholar
  29. Shear, MK, Brown, TA, Barlow, DH, Money, R, Sholomskas, D, Woods, S, Gorman, J, Papp, L 1997Multicenter collaborative panic disorder severity scaleAm J Psychiatry15415711575PubMedGoogle Scholar
  30. Sheikh, JI, Londborg, P,  et al. 2000The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies (Eng)Int Clin Psychopharmacol15335342PubMedCrossRefGoogle Scholar
  31. Starcevic, V, Djordjevic, A, Latas, M, Bogojevic, G 1998Characteristics of agoraphobia in women and men with panic disorder with agoraphobiaDepress Anxiety8813CrossRefPubMedGoogle Scholar
  32. Stein, MB, Walker, JR, Anderson, G, Hazen, A, Ross, C, Eldridge, G, Forde, D 1996Childhood physical and sexual abuse in patients with anxiety disorders and in a community sampleAm J Psychiatry153275277PubMedGoogle Scholar
  33. Turgeon, L, Marchand, A, Dupuis, G 1998Clinical features in panic disorder with agoraphobia: a comparison of men and womenJ Anxiety Disord12539553CrossRefPubMedGoogle Scholar
  34. Yonkers, KA, Zlotnick, C, Allsworth, J, Warshaw, M, Shea, T, Keller, M 1998Is the course of panic disorder the same in women and men?Am J Psychiatry155596602PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • A. H. Clayton
    • 1
  • R. S. Stewart
    • 2
  • R. Fayyad
    • 3
  • C. M. Clary
    • 3
  1. 1.University of Virginia School of MedicineCharlottesvilleUSA
  2. 2.University of Texas Southwestern Medical CenterTexasUSA
  3. 3.Pfizer, Inc.New YorkUSA

Personalised recommendations